CHO Pharma, Inc.

CHO Pharma, Inc. financial statements

CHO Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueTWD 1.43MEODHD
Net income−TWD 290.01MEODHD
Cash and equivalentsTWD 52.09MEODHD

CHO Pharma, Inc. financials on 6ix · CHO Pharma, Inc. on 6ix